Drugs · acquisition-cost intelligence
Bliss GVS
Glycerin· ingredient glycerinEnemas· GLYCERIN 2 g/1; GLYCERIN 2 g/2.5g
What this is. Acquisition-cost intelligence for pharmacy & clinic buyers — the historical trend, generic-equivalent costs, and Part D posture. NADAC is a pharmacy acquisition cost (the national average pharmacies pay), not a retail or cash price — for consumer cash prices use GoodRx/your plan.
Acquisition benchmark · NADAC per EA
$0.11147
NADAC — pharmacy acquisition cost, not a retail/cash price
Acquisition-cost history
Weekly NADAC per EA — the trend nobody else shows. 8 weeks.
2025-12-172026-05-20
Same-ingredient options by acquisition cost
Other glycerin products, cheapest acquisition cost first. Per EA — confirm strength/form equivalence before switching.
| Product | NADAC / EA | vs this |
|---|---|---|
| Glycerin | $0.09001 | −$0.02150 |
| Clear Eyes Redness Relief | $0.09769 | −$0.01380 |
| Glycerin | $0.11291 | +$0.00140 |
| Bliss GVS Children | $0.11291 | +$0.00140 |
| Fleet | $0.12834 | +$0.01690 |
| Pedia-Lax | $0.20824 | +$0.09680 |
Sources: CMS NADAC (pharmacy acquisition cost), FDA NDC + RxNorm (identity), RxClass (therapeutic class), CMS Medicare Part D formulary (coverage). Observed reference data for professional buyers — not a retail/cash price, not pricing or medical advice. Verify before purchasing or substituting.